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ABSTRACT
A transcriptional feedback loop is the simplest and
most direct means for a transcription factor to
provide an increased stability of gene expression.
In this work performed in human cells, we reveal a
new negative auto-regulatory mechanism involving
an alternative transcription start site (TSS) usage.
Using the activating transcription factor ZNF143 as
a model, we show that the ZNF143 low-affinity
binding sites, located downstream of its canonical
TSS, play the role of protein sensors to induce the
up- or down-regulation of ZNF143 gene expression.
We uncovered that the TSS switch that mediates
this regulation implies the differential expression
of two transcripts with an opposite protein produc-
tion ability due to their different 50 untranslated
regions. Moreover, our analysis of the ENCODE
data suggests that this mechanism could be used
by other transcription factors to rapidly respond to
their own aberrant expression level.
INTRODUCTION
Maintaining the adequate gene expression pattern in cells
is an essential feature of multicellular complexity and
diversity. This regulation is achieved through multiple
factors that act at the transcriptional and/or post-
transcriptional level. The major regions involved in this
regulation are untranslated regions of messenger RNAs
(50 UTRs and 30 UTRS), introns and cis-regulatory
regions on DNA (1). Alternative promoter usage and
alternative splicing largely contribute to the generation
of transcripts that are differentially regulated (1–3).
These transcripts could have diverse exons composition
and/or contain altered 50 UTRs and 30 UTRs (1,4,5).
Auto-regulation is one of the simplest and the most
efﬁcient regulatory mechanism used by the cell to
maintain the proper gene expression at multiple levels.
Good examples are RNA-binding proteins such as TDP-
43 (6,7) and HuR (8) that regulate their expression by
targeting and affecting the stability of their own mRNA.
At the transcriptional level, auto-regulatory loops are
highly conserved in vertebrate evolution (9) and are well
described from the lambda phage to more complex higher
eukaryotes (10). The principal beneﬁt of such mechanisms
is to restore rapidly and efﬁciently the homeostasis of
proteins in the cells. In this regard, it has been
demonstrated that the negative auto-regulation of tran-
scription factors speeds up the response times of transcrip-
tion networks and provides stability by limiting the range
over which the concentrations of network components
ﬂuctuate (11,12). Transcriptional auto-regulation can be
mediated by direct interactions as for BRCA1 (13) or
indirectly as for the auto-regulatory network of p53 (14).
Another well-described complex transcriptional auto-
regulatory network involves OCT4, SOX2 and NANOG
pluripotency transcription factors in embryonic stem cells
(15–17). To date, only few direct transcriptional feedback
loops have been reported including PAX4, Hes1, BRCA1,
HNF4a, OCT4, SOX2 and NANOG (13,15,18–20).
However, the mechanistic insights of such regulations
have not been fully explored. Taking in consideration
the vast and functionally varied transcription factor popu-
lation in human (21), as well as their potential involvement
in feedback loops (9), we could expect a wide diversity of
transcriptional auto-regulatory mechanisms.
ZNF143 is a zinc-ﬁnger transcription factor regulating
dozens of non-coding genes and more than 3000 protein
coding genes (22). Targeted genes are essentially involved
in rapid cell proliferation (22,23), are required for the
normal development (24) and are important to the self-
renewal and maintenance of embryonic stem cells (25–27).
It has been previously shown that ZNF143, also known as
Staf, is required for the normal expression of the essential
tRNASec gene (28–30). ZNF143 has a vertebrate-speciﬁc
paralog called ZNF76 (31). The two proteins that share
63% of identity, have exactly the same DNA-binding
domain (DBD), are both able to activate transcription
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and have the same binding proﬁle in vivo (22,31). Both
repressor and activator functions have been attributed
to ZNF76 (31,32), however, its role in vivo remains
unknown.
To date, nothing was known about the transcriptional
mechanisms underlying the expression of ZNF143. In this
study, we present evidence of a feedback loop mechanism
that acts at the transcriptional level to regulate ZNF143
expression. We demonstrate that a transcriptional activa-
tor can negatively regulate its own expression when over-
expressed in the cell. In addition, this study represents the
ﬁrst evidence of a transcriptional auto-regulatory mechan-
ism, relaying on the use of non-canonical binding sites, as
sensors to trigger a transcriptional start site (TSS) switch.
Finally, we hypothesize that this mechanism could
certainly represent a more general transcriptional auto-
regulation strategy.
MATERIALS AND METHODS
Antibodies and constructs
Antibodies and constructs used in this study are described
in Supplementary Materials and Methods.
Cell lines and induced protein expression and knockdown
All the cell lines were maintained in standard DMEM
medium supplemented with 10% Fetal Calf Serum and
1% Pen-Step (GIBCO). The FLP143, FLP143-HA,
FLP_THAP11-HA and FLP76 inducible stable cell lines
were obtained and maintained as described in (22). The
FLP143-EGR2 cell line was obtained as described in (22)
using the pGMC plasmid (see Supplementary Materials
and Methods) expressing a chimeric ZNF143 protein
(ZNF143-EGR2) wherein the seven zinc ﬁngers DBD
was substituted by that of EGR2 (also known as
KROX20) (31) composed of three zinc ﬁngers. Protein
expression was induced by the addition of 1 mg/ml of
doxycycline in the culture medium. The SH1_7 stable
cell line was obtained after the puromycin selection
(5mg/ml) of T-rex 293 cells transduced with PTRIPZ
lentiviral inducible shRNAmir V3THS_308811 (Thermo
Scientiﬁc) targeting ZNF143 transcript. The knockdown
was induced by the addition of 1 mg/ml of doxycycline in
the culture medium.
RNA preparation and expression analysis
The ectopic gene expression in the stable cell lines was
induced with doxycycline, and the cells were collected at
different time points post-induction. Total RNA was
extracted using TRI-REAGENT (Euromedex), and
Poly(A)+ RNA was enriched from total RNA
usingmMACS mRNA Isolation Kit (Miltenyi Biotec).
The cDNA obtained by reverse transcription with
random primers (dN9) was ampliﬁed with speciﬁc
primers on the CFX96 TouchTM Real-Time PCR
Detection System (Bio-Rad) using EvaGreen qPCR Mix
Plus (Euromedex). Primer sequences are available in
Supplementary Table S1. All reactions were carried out
in triplicate. The relative expression ratio was calculated
using the CFX ManagerTM Software (Bio-Rad). The
tissue qPCR arrays gene expression analysis was per-
formed on human disease tissues (TissueScanTM Cancer
Survey Tissue qPCR Panel 96 – I CSRT101, OriGene) and
on mouse tissues (TissueScanTM Mouse developmental
Tissue qPCR Panel I MDRT101, OriGene). The cDNAs
from human and mouse qPCR arrays were normalized
against ß-actin and GAPDH levels, respectively. The
relative expression was calculated using theCt method.
Protein preparation and western-blot analysis
Cells were collected at different time points post-induction
and lysed. The proteins from the lysate were separated on
an 8% SDS–PAGE and subjected to western-blot analysis
using antibodies against ZNF143, a-tubulin and TBP. The
western-blot signal quantiﬁcation was performed on
Quantity One Software (Bio-Rad).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were per-
formed as previously described (22). The average fragment
size of the sheared DNA is of 200–400 bp. After DNA
puriﬁcation, enrichment analysis was performed by quan-
titative real time PCR (qPCR). qPCR was performed in
triplicates on a CFX96 TouchTM Real-Time PCR
Detection System (Bio-Rad) using EvaGreen qPCR Mix
Plus (Euromedex) and input DNA as the standard. The
input DNA was diluted 500 times compared with the
ChIPed DNA to measure the enrichment of speciﬁc
genomic regions relative to the negative control regions
devoid of the studied binding sites. Enrichment was
determined by the Ct method. Primer sequences are
available in Supplementary Table S1.
Northern blot
FLP143 or SH1_7 cells were treated with 1 mg/ml of doxy-
cycline 48 h prior the transfection performed using
LipofectamineTM 2000 (Invitrogen) according to the
manufacturer’s instructions. The total RNA was isolated
24 h post-transfection and treated with recombinant
DNase I (Roche). RNA samples [20–30 mg of total RNA
or 5 mg of poly(A)+ enriched RNA] were loaded on 1%
formaldehyde agarose gels, transferred onto a Hybond
N+ nylon membrane (Amersham Biosciences), UV
crosslinked (UV Stratalinker 1800, Stratagene) and
probed with internally 32P labeled RNA or 50 32P labeled
oligodeoxynucleotides. RNA probes were synthesized by
in vitro T7 transcription with a32P labeled ATP using
speciﬁc PCR templates. The sequences of the primers
used to amplify the PCR templates are available in
Supplementary materials (Supplementary Table S1). The
prehybridization and hybridization were carried out using
PerfectHybTMPlus Solution (Sigma) at 42C and the
washes performed according to the supplier’s recommen-
dations. Transcripts were visualized and quantiﬁed with a
Fujiﬁlm Bio-Imaging Analyzer System.
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Luciferase assay
FLP143 and SH1_7 cells were induced or not induced with
doxycycline 48 h prior the transfection in 96 wells plates
with the different luciferase constructs. The luciferase
assay was performed 24 h post-transfection using the
Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer recommendations. The
luminescence signal was measured on a GloMax 96
Microplate Luminometer (Promega). Each essay was per-
formed in three biological replicates, and the Renilla
luciferase signal was normalized to the ﬁreﬂy luciferase
activity.
50 RACE-PCR
The 50 RACE-PCR experiment was performed using the
FirstChoice RLM-RACE Kit (Life Technologies)
according to the manufacturer recommendations on
total RNA extracted from FLP143 cells treated or not
with 1 mg/ml of doxycycline. The endogenous ZNF143
cDNA was targeted with two gene-speciﬁc inner/outer
PCR primer pairs: PN627/PN628 and PN625/PN626
(Supplementary Table S1). The cDNA from transfected
pNG107 construct was targeted with two speciﬁc inner/
outer PCR primer pairs: PN270/PN500 and PN270/
PN640 (Supplementary Table S1). The nested-PCR
products were analyzed on 2% agarose gel and sequenced
to identify the 50 end of the targeted mRNA.
Electromobility shift assay
Recombinant ZNF143 DBD was produced using the GST
gene fusion system as previously described (22). The DNA
fragments containing the SBS/A, SBS/B, mut SBS/B,
SBS/C and mut SBS/C binding sites were obtained
by annealing two complementary oligonucleotides 50
32P-labeled (Supplementary Table S1). Binding assays
were performed essentially as described (33) with 20 fmol
of labeled probe. Protein–DNA complexes were resolved
by electrophoresis on 4% native polyacrylamide gels con-
taining 0.25 Tris-borate-EDTA. Competition was
performed with a 200-fold molar excess of unlabeled
speciﬁc competitor or unspeciﬁc competitor.
Determinations of relative binding afﬁnities
Quantitative competitive electromobility shift assay
(EMSA) was used to compare the relative afﬁnities of
the ZNF143-binding sites as described previously (34).
Brieﬂy, the recombinant ZNF143 DBD was incubated
for 20min at room temperature with zero and increasing
concentrations of the unlabeled oligonucleotide duplex
probes containing SBS/B, SBS/C and optimal SBS site
from the BUB1B promoter (33). The labeled probe con-
taining the optimal SBS site was then added to a ﬁnal
volume of 10 ml. Following electrophoresis, the bound
probe was quantiﬁed (Using Fujiﬁlm Bio-Imaging
Analyzer System), and the fraction of maximal binding
at each competitor concentration was calculated as the
ratio of bound probe plus competitor to bound probe
with no competitor. An unspeciﬁc competitor, devoid of
ZNF143-binding site, has been used as a negative control.
A curve was then ﬁtted to the values for the fraction
of maximal binding at known competitor DNA
concentrations.
ChIP-seq data
In this study, we used the ZNF143 ChIP-seq data from
our previous study (Geo access: GSE39263) (22) and
Encode ChIP-seq data on TAF1 and TBP in HeLa cells
as well as on 87 other sequence-speciﬁc transcription
factors (35).
RESULTS
Induced ectopic ZNF143 over-expression downregulates
the endogenous ZNF143 expression
We generated stable cell lines expressing an HA-tagged
(FLP143-HA) or a non-tagged ZNF143 protein (FLP143)
under the control of an inducible promoter. Interestingly,
we observed that the doxycycline-induced ectopic expres-
sion of ZNF143-HA resulted in a decrease in the endogen-
ous ZNF143 protein level as seen by western blot
(Figure 1A, take in account the TBP signal). The produc-
tion of the ZNF143-HA protein is detectable already 3h
post-induction, and its level rapidly increases over the time.
In contrast, the endogenous ZNF143 protein that is dis-
tinctly detected up to 12h disappears 24h post-induction
of the transgene expression (Figure 1A). The down-
regulation of the endogenous ZNF143 is observed not
only at the protein level but also at the mRNA level. We
followed speciﬁcally by RT-qPCR the endogenous ZNF143
mRNA using primers that target the 50 UTR, absent in the
induced gene. The transgenic mRNA was followed using
primers targeting speciﬁcally the HA-tag. After induction,
we observed that the ZNF143-HA mRNA level rapidly
increases by 10 times after 24h (Figure 1B). At the same
time, the endogenous ZNF143 mRNA level is decreased 6 h
post-induction and is declining continuously by more than
10 times after 24–48h (Figure 1B). In comparison, the
expression of known ZNF143 target genes ZMAT5,
FEN1, IRF3, TCP1, BUB1B and TFAM (33,36–39) is
increased up to two times after 24h (Figure 1B). This
drastic ZNF143 down-regulation was also conﬁrmed by
northern-blot analysis of ZNF143 mRNA in FLP143
cells over-expressing a non-tagged version of ZNF143
(Supplementary Figure S1A). Moreover, we observed that
this phenomenon is reversible. Indeed, after the inductor
withdrawal in FLP143 cells, the endogenous ZNF143
expression level returned to normal both at the protein
and mRNA levels (Supplementary Figure S1B and C).
ZNF143 down-regulation is also induced by ZNF76
over-expression
To test if the aforementioned phenomenon is restricted to
ZNF143, we monitored the endogenous expression of two
other transcription factors following the over-expression
of their analogous transgenes. For this purpose, we used
FLP76, FLP_THAP11-HA, FLP143 and FLP-mock
(control) inducible stable cell lines over-expressing,
respectively, ZNF76, THAP11-HA, ZNF143 and
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no-protein. ZNF76 was previously characterized as the
ZNF143 paralog with the same DNA-binding speciﬁcities
(31). THAP11 in this assay was used as a control. Gene
expression analysis was performed before induction with
doxycycline and 24–48h post-induction (Figure 1C).
Total ZNF143, ZNF76 and THAP11 mRNA levels were
highly increased after induction in FLP143, FLP76 and
FLP_THAP11-HA cell lines, respectively. The doxycycline
induction had no effect on the endogenous ZNF143,
ZNF76 and THAP11 expression in the empty control
stable cell line (Mock). THAP11-HA over-expression had
as well no impact on ZNF143, ZNF76 and THAP11 levels.
Surprisingly, alike ZNF143, ZNF76 over-expression caused
a 10-time fold down-regulation of the endogenous
ZNF143. However, the level of the endogenous ZNF76
mRNA was not affected by any of the proteins. This
ZNF76 mediated down-regulation of ZNF143 was also
observed at the protein level (data not shown), suggesting
that the DNA-binding speciﬁcities of ZNF143 and ZNF76
mediate the observed regulation. To endorse this assump-
tion, we generated a stable cell line expressing a chimeric
ZNF143 with an altered DBD. The chimeric protein was
obtained by substituting the DBD of ZNF143 by that of
the EGR2 protein, also known as KROX20 (31). After the
induction of the expression of the ZNF143-EGR2 protein,
we see no changes in the expression of the endogenous
ZNF143 (Figure 1D, right panel). The level of the
chimeric protein is increased 6 and 24h after induction,
while the level of the endogenous ZNF143 stays constant.
In contrast, the induction of the HA-tagged ZNF143
protein causes a speciﬁc down-regulation of its endogenous
counterpart (Figure 1D, left panel). We conclude that the
DBD of ZNF143 is therefore required for the observed
down-regulation of the endogenous protein.
ZNF143 binds its own minimal promoter region
The accumulation of ZNF143 after the induction of FLP
cell lines suggested that the ZNF143 transgene, unlike the
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Figure 1. The over-expression of a ZNF143 and ZNF76 transgene speciﬁcally represses the expression of the endogenous ZNF143 gene. (A) Western
blotting performed with ZNF143 antibody on total protein extracts from FLP143HA cells at different times points (in h) after induction of the
expression of the ZNF143-HA protein. The arrows indicate the endogenous ZNF143 (68.8 kDa) and the tagged ZNF143-HA (72.4 kDa) proteins.
The TBP protein is used as loading control. (B) Gene expression measured by RT-qPCR on total RNA extracted from FLP143HA cells at different
time points (in h) post-induction with doxycycline. The relative expression of the ZNF143 endogenous mRNA (endo ZNF143) was followed using
primers speciﬁc to the 50 UTR region. The transgene ZNF143-HA, ZMAT5, FEN1, IFR3, TCP1, BUB1B and TFAM were also followed over the
same time course. The relative expression was normalized to both the TBP and UBC gene expression levels. The error bar for the endo ZNF143
expression is the standard deviation of two biological replicates. (C) Gene expression measured by RT-qPCR on total RNA extracted from FLP-
mock (control) and from FLP143, FLP76, FLP_THAP11-HA stable cell lines at 0 (black), 24 (gray) and 48 h (white) post-treatment with doxy-
cycline. The relative expression of each endogenous gene (endo ZNF143, endo ZNF76 and endo THAP11) and transgene (ZNF76, ZNF143 and
THAP11-HA) for each cell type is represented on the x-axis. The expression is normalized to the GAPDH levels, and the error bar is the standard
deviation of three replicates. (D) The endogenous ZNF143 protein expression was followed by western blot, after the over-expression of a chimeric
ZNF143 with impaired DNA-binding speciﬁcity. The chimeric ZNF143-EGR2 protein was obtained by substituting the DBD of ZNF143 by that of
EGR2 (KROX20) protein. Stable cell lines expressing the tagged (ZNF143-HA) or the chimeric (ZNF143-ERG2) proteins were induced for 6 and
24 h with doxycycline. The resulting protein extract was analyzed by western blot with anti-ZNF143 antibodies. The arrows indicate the endogenous
ZNF143 (68.8 kDa), the tagged ZNF143-HA (72.4 kDa) and the chimeric (57.72 kDa) proteins. The a-tubulin is used as loading control.
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endogenous ZNF143, was not subjected to a negative
feedback loop. From the ChIP-seq data generated in our
previous study (22), we identiﬁed a ZNF143-binding
event, centered on the middle part of the ZNF143 ﬁrst
exon, in all human and mouse cell lines tested
(Figure 2A; Supplementary Figure S2A). The presence
of this peak suggests the possibility of an auto-regulatory
feedback in the control of ZNF143 transcription. As a
prerequisite to the investigation of this phenomenon, we
deﬁned in a ﬁrst attempt the ZNF143 minimal promoter.
We engineered a Renilla luciferase reporter construct
headed by the 593 nt located upstream of the TSS, the
ﬁrst exon (+1/+112) and the shortened ZNF143 ﬁrst
intron (50-part: +113/+234 associated with the 30-part:
+10170/+ 10344) (Figure 2B). We transiently transfected
293T-rex cells with the luciferase reporter constructs con-
taining a progressively shortened 50 upstream regions and
measured the luciferase activity of the resulting cell
extracts (Figure 2B). The highest luciferase activity was
observed for the largest construct 593. The activity
decreased progressively to 30% for the 73 construct
and was almost abolished for the shortest 25 construct.
The region, essential to maintain signiﬁcant transcrip-
tional activity, was located between the 73 and 25.
This allowed us to restrict our study to a region
covering positions 73 bp to +234 relative to the TSS.
Surprisingly, this minimal region contains a 98-bp
element (+54/+151) with a high degree of sequence con-
servation in vertebrates (Figure 2C), located in the ﬁrst
non-coding exon and in the beginning of the adjacent
intron. Such conservation of non-coding gene elements
suggests a putative important regulatory role for this
region. Computational analysis of the 75/+234 region
with the MatInspector software (40) revealed the
presence of interesting motifs. The conserved intronic
region contains a TATA-box like element (Figure 2C, pos-
ition+120 relative to TSS) and an Initiator element (Inr,
TTATTC position +147) located 25 bp after the TATA-
box (Figure 2C). ChIP-Seq data from the ENCODE con-
sortium suggests strongly that the TATA-box and the Inr
element are bound by TBP and TAF1, respectively
(Supplementary Figure S2B). The region 75/+234 also
contains three potential ZNF143-binding motifs: SBS/A
(position 15), SBS/B (position +80) and SBS/C
(position +133), with the SBS/B and SBS/C being
conserved in vertebrates genomes (Figure 2C). The three
SBS matched the consensus ZNF143-binding motif with a
relatively low score (A: 0,800; B: 0,797; C: 0,823, respect-
ively) (Figure 2D), likely reﬂecting a non-optimal binding
of ZNF143 at these sites (34). By performing EMSA, we
found that the ZNF143 DBD (Figure 2E, lanes 2–4 and
lanes 6–8) binds speciﬁcally the SBS/B (located in the non-
coding exon) and SBS/C (located in the intron) but not the
SBS/A (Figure 2E, lane 10). In addition, point mutations
in critical positions 3–6 (34) of the SBS/B and C motifs,
completely abolish the ZNF143 binding in vitro, as
illustrated in Figure 2E for SBS/C (compare lanes 14
and 16). The relative afﬁnities of the SBS/B and SBS/C
sites compare to an optimal binding site [taken from
BUB1B promoter (33)] were evaluated by in vitro quanti-
tative competitive binding assays (Figure 2F). The relative
capacities of increasing concentrations of the SBS/B, SBS/
C and the optimal site to compete for the binding to the
ZNF143 with a constant concentration of the labeled
optimal site were assessed. The ZNF143-DNA binding
competition assay convincingly demonstrates that in our
experimental conditions, both the SBS/B and SBS/C sites
have a lower binding capacity to ZNF143 compared to an
optimal binding site (BUB1B site). Indeed, at a concentra-
tion inhibiting 50% of the maximal binding, ZNF143
binds about 18 and 80 times more tightly the optimal
sequence than to the SBS/C and SBS/B motifs, respect-
ively. We next examined the ZNF143 occupancy on its
own promoter region by ChIP-qPCR after ZNF143
over-expression (Figure 2G). The FLP143 cells over-
expressing ZNF143 were used for ChIP experiments
with antibodies speciﬁc to ZNF143 at different time
points post-induction. The ChIP enrichment relative to
the control regions is increased by more than two times
on the ZNF143 promoter after its own ectopic over-
expression (Figure 2G). On the other hand, ZNF143 oc-
cupancy did not vary on the ATP5J promoter (Figure 2G)
containing an SBS consensus motif (22). This ZNF143
ampliﬁed binding to its promoter region is most likely a
reﬂection of the lower afﬁnity of ZNF143 to SBS/B and
SBS/C sites.
A ZNF143 transcript variant is initiated in the ﬁrst
canonical intron
Taken together, all the observations described above
suggest a putative regulation of ZNF143 expression
at the transcriptional level. In this regard, we ﬁrst
examined by ChIP-qPCR the presence of RNA polymer-
ase II (Pol II) and histone modiﬁcation marks (H3K4me3
and H3K9me3) on the ZNF143 promoter region before
and 24 h post-induction (Supplementary Figure S3). We
did not observe any enrichment for H3K9me3 repression
marks. On the other hand, we obtained similar Pol II en-
richments before and after induction, showing that this
region stays in a transcriptionally active state. Histone
H3K4me3 activation mark showed a slightly lower enrich-
ment 24 h post-induction, suggesting a different chromatin
context. In a second step, we mapped the TSS of ZNF143
by 50 RACE-PCR on total RNA extracted from FLP143
cells before and after induction. Two families of TSS were
identiﬁed in non- and 24 h-induced conditions (Figure 3A;
Supplementary Figure S4A). The ﬁrst family (TSS1) is
located in a 90-bp window close to the reference TSS
(NM_003442). The second family (TSS2) is located at
148–149 bp from the reference TSS, in the putative Inr
element at the beginning of the ﬁrst intron (Figure 2C;
Supplementary Figure S4A). These 50 RACE-PCR data
are supported by the presence of two populations of ex-
pressed sequence tags (41) one initiated in the TSS1
window and the other (TSS2) in the ZNF143 ﬁrst intron
(Supplementary Figure S4B). The sequencing of a cDNA
clone H04D117B14 (obtained from the RIKEN human
cDNA library) initiated at the TSS2, combined with the
50 RACE-PCR results, clearly evidenced the presence
of an alternative ﬁrst non-coding exon (Exon 1 b)
(Figure 3A; Supplementary Figure S4C). The two
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Figure 2. ZNF143 occupies its own minimal promoter region. (A) UCSC genome browser view of a ZNF143 ChIP-seq peak (22) located on its own
promoter region. (B) Identiﬁcation of the 50 minimal region required for the activity of ZNF143 promoter. Left part, schematic representation of the
constructs containing the shortened upstream promoter regions, the ﬁrst non-coding exon (112 bp) and the truncated ZNF143 ﬁrst intron (302 bp), in
front of the Renilla luciferase gene (Luc). The truncated intron contains the 50-part (+113/+234) linked to the 30-part (+10170/+10344) of the intron.
The shortened upstream regions are indicated in base pairs relative to the ZNF143 TSS (+1). The numbering (+1) starts from the ﬁrst nucleotide of
the RefSeq sequence NM_003442. The psiCHECK-2 vector containing the SV40 promoter is used as a reference. Right part, relative Renilla
luciferase activity of each construct normalized to the ﬁreﬂy luciferase activity. The error bar corresponds to the standard deviation of three
biological replicates. (C) Multiple sequence alignment of the ZNF143 region spanning the TSS in human (H_sapiens), mouse (M_musculus),
zebra ﬁsh (D_rerio) and xenope (X_tropicalis). The conserved nucleotides are indicated with a star. An arrow (+1) indicates the TSS; the ﬁrst
non-coding exon is framed in black. The potential ZNF143-binding sites (SBS/A, SBS/B and SBS/C), a TATA box-like and an initiator (Inr) element
are highlighted in gray. (D) Comparison of the SBS/A, SBS/B, SBS/C and SBS consensus sequence (42), (Y, N and R stand for T/C, any nucleotide
and A/G, respectively). (E) Electrophoretic mobility shift assay performed with the 32P labeled oligonucleotides probes corresponding to the putative
ZNF143-binding sites: SBS/A (lanes 9–12), SBS/B (lanes 5–8), SBS/C (lanes 1–4) and the mutated SBS/C (CCCA substituted to AAAC, lanes 13–16).
Probes were incubated in the absence (lanes 1, 5, 9, 13 and 15) or presence of ZNF143 DBD (lanes 2, 3, 4, 6, 7, 8, 10, 11, 12, 14 and 16). Reactions
were performed in the presence of a 1000-fold molar excess of unlabeled speciﬁc competitor (sp.) (lanes 3, 7 and 11) and unspeciﬁc competitor (unsp.)
(lanes 4, 8 and 12). (F) Measurements of the relative binding afﬁnities of the ZNF143-binding domain to the SBS/C, SBS/B and the optimal SBS site
from BUB1B promoter (33). Relative afﬁnities of different sequences were determined by comparing their effectiveness as binding competitors.
Various concentrations of unlabeled oligonucleotides containing the sites were pre-incubated with equal concentrations of ZNF143 DBD. A constant
amount of labeled probe containing the optimal sequence (from BUB1B promoter) was subsequently added. After the binding equilibrium was
reached, the extent of competition was analyzed following gel electrophoresis as described in ‘Materials and Methods’ section. An unspeciﬁc (unsp)
competitor, devoid of ZNF143-binding site, has been used as a negative control. (G) ChIP experiment with ZNF143 antibodies performed on
FLP143 cells: before induction of ZNF143 over-expression with doxycycline (0 hpi), 6, 12 and 24 h post-induction (hpi). The enrichments were
measured by qPCR using primers speciﬁc to regions located: 150 bp upstream the ZNF143 TSS (+1)(ZNF143 promoter), in the ATP5J promoter
region containing an SBS site and in the GAPDH promoter region devoid of SBS site. The enrichment was calculated compared to a non-speciﬁc
region located 1 kb downstream of the ZNF143 TSS and using the input DNA as a standard. The error bar corresponds to the standard deviation of
three replicates.
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populations of ZNF143 transcripts (TSS1 and TSS2 tran-
scripts) (Figure 3A; Supplementary Figure S4) have
exactly the same coding sequence (CDS) but have strik-
ingly different 50 UTRs. The canonical TSS1 transcript
has a 119 nt long 50 UTR composed of one non-coding
exon, whereas the alternative TSS2 transcript has a
1222 nt long 50 UTR composed of four non-coding
exons (Supplementary Figure S4C). Only a 7-bp region
located in 30 of the 50 UTRs, coming from the coding
exon, is common to both transcripts (Supplementary
Figure S4C). Taking advantage of the differences in
50 UTR, we speciﬁcally followed both TSS1 and TSS2
transcripts by RT-qPCR in cells over-expressing or not
ZNF143. Before induction, we noted the considerable dif-
ference in the number of cycles required for the TSS1 and
TSS2 transcripts detection (Supplementary Figure S4D).
Considering the six cycles difference, the TSS2 transcript
is around 20 times less present than the TSS1 transcript
before ZNF143 over-expression. After the induction of
FLP143 cells, the total level of ZNF143 mRNA in the
cell goes up by four times already after 6 h (Figure 3B),
while the endogenous ZNF143 mRNA (TSS1+TSS2)
goes progressively down by eight times after 24 h
(Figure 3B). However, if we look distinctly at the TSS1
and TSS2 transcripts we observe that the TSS1 transcript
level drops down drastically by more than 10 times after
24 h, while the TSS2 transcript level stays constant or is
slightly increased (Figure 3B). To test if the TSS2 tran-
script was prone to produce the ZNF143 protein, we
transfected 293 T-rex cells, with plasmids expressing
the TSS1 or TSS2 full-length cDNA, and followed the
protein expression by western blot (Figure 3C). The
over-expression of the TSS1 transcript in the cells, as
expected, resulted in higher ZNF143 protein level
compared to the mock-transfected cells (Figure 3C). In
contrast, the over-expression of the TSS2 transcript does
not result in signiﬁcant production of the ZNF143 protein
compared to the control cells (Figure 3C).
Taken together these observations show that ZNF143
over-expression induces a TSS switch, from one
generating the canonical TSS1 transcript to another
one producing a less abundant and untranslated TSS2
transcript.
ZNF143 auto-regulation involves a TSS switch
dependent on non-canonical SBS sites
To better investigate the transcriptional auto-regulation
mechanism, we used the heterologous luciferase reporter
system already used to deﬁne the ZNF143 promoter
(Figure 2B). In this system the minimal ZNF143
promoter proximal region (73/+234) including the TSS1
and the TSS2 regions was placed in front of a Renilla
luciferase gene. To reproduce the endogenous situation,
the construct also contains a truncated splicing-competent
version of the ZNF143 ﬁrst intron placed before the
luciferase CDS (Figure 4A). We conﬁrmed by 50 RACE-
PCR that this reporter construct mimics the endogenous
situation by producing a TSS1 spliced transcript and a
TSS2 transcript initiated in the intron (Figure 4A). We per-
formed substitutions in the SBS/B and C core sequences
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ZNF143 gene and of the two transcripts (TSS1 and TSS2 transcripts) identiﬁed by 50 RACE PCR in total RNA from both induced and non-induced
FLP143 cells. The TSSs are represented with arrows. The TSS1 transcript initiated at TSS1 contains the ﬁrst non-coding exon (Exon1a) spliced to the
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ZNF143 gene expression measured by qRT-PCR from total RNA extracted from FLP143 cells at multiple time points (in h) post-induction with
doxycycline. The expression of the two endogenous ZNF143 alternative transcripts (ZNF143 TSS1 or ZNF143 TSS2), the total (endogenous and
transgene) ZNF143 transcripts (ZNF143 Total) and the total endogenous transcripts (ZNF143 TSS1+TSS2) were measured using speciﬁc primers
located, respectively, in the Exon1a, Exon1b, the CDS and 30 untranslated region (Supplementary Table S1). The expression is normalized to the
GAPDH levels, and the error bar is the standard deviation of three replicates. (C) 293 T-rex cells were transfected with pcDNA 3.1 constructs
expressing the full-length TSS1 or TSS2 cDNAs. As a control, the cells were transfected with the empty pcDNA3.1 vector (mock). Left panel,
western-blot analysis of ZNF143 protein level 48 h post-transfection in the control cells (mock) or after over-expression of the TSS1 or the TSS2
transcripts. Right panel, relative expression of TSS1 and TSS2 transcripts, measured by RT-qPCR, in total RNA from cells transfected with the
TSS1 and TSS2 constructs.
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Figure 4. ZNF143 transcriptional auto-regulation involves a TSS switch mechanism using non-canonical SBS sites. (A) Schematic representation of
the used heterologous system. The construct contains the region upstream (73 bp) of the ZNF143 TSS, the ﬁrst non-coding exon (Exon1) and the
splicing competent truncated ZNF143 ﬁrst intron fused to the CDS of the Renilla luciferase. The spliced TSS1 is indicated in green and dashed red.
The TSS2 transcript is not spliced and is indicated in plain green and red. The probes targeting the ﬁrst exon (probe 1), the intron (probe 2) and the
CDS of the Renilla luciferase (probe 3) are depicted. (B) Sequence of the ZNF143 promoter region cloned in the reporter construct. The TSSs,
canonical (TSS1) and alternative (TSS2) are represented with an arrow. The ZNF143 ﬁrst non-coding exon is framed, and both SBS/B and SBS/C
sites are highlighted in gray. All the mutated positions are underlined, and the substituted sequences are indicated in lowercase. SBS/B and SBS/C
correspond to mutations in the SBS site. SBS/B+and SBS/C+are creating high afﬁnity consensus ZNF143-binding sites (42). The mutations mut 1
to mut 5 correspond to mutation in other regions of the conserved sequence block (Figure 2C). (C) Northern-blot analysis of the transcripts derived
from transfected indicated constructs in FLP143 cells before () and after (+) 48 h doxycycline induction. The constructs are carrying the mutations
indicated in (B). The mut SBS and the mut SBS+construct bear both the mut SBS/B and mut SBS/C mutations indicated in (B). All the constructs
express the ﬁreﬂy luciferase gene under the control of a HSV-TK promoter. TSS1, TSS2 transcripts, Fireﬂy luciferase CDS and GAPDH mRNA
were detected with speciﬁc probes depicted in (A) for TSS1 and TSS2 transcripts. Fireﬂy signal is used as an internal standard to normalize to Renilla
signal and GAPDH signal serves as a loading control. (D) Luciferase assay performed with the different reporter constructs in ZNF143 over-
expression and knockdown conditions. Left panel, relative Renilla luciferase activity in non-induced and induced (over-expression) FLP143 cells
transfected with the WT construct, mutated in SBS/C (mut SBS/C), mutated in SBS/B (mut SBS/B) and mutated in both SBS/C and SBS/B (mut
SBS). SV40 promoter is used as negative control. The Renilla luciferase signal was normalized to the ﬁreﬂy luciferase signal. Right panel, Renilla
luciferase activity signal in non-induced and induced (knockdown) SH1_7 cells, with WT and mut SBS. (E) ZNF143 expression measured by
western blot (left panel) and RT-qPCR (right panel) in SH1_7 stable cell line before () and 72 h post-induction (+) with doxycycline. Tubulin levels
serves as a loading control for the western blot. ZNF143 mRNA levels are normalized to TBP and UBC expression levels. (F) Northern-blot analysis
of the transcripts derived from the transfected indicated constructs in the FLP143 and SH1_7 cells before () and after (+) 48 h doxycycline
induction. SV40 promoter is used as control. All the constructs express the ﬁreﬂy luciferase gene under the control of a HSV-TK promoter. The
transcripts are detected as in (C). The left panel corresponds to a representative northern-blot signal, and the right panel is the normalized quan-
tiﬁcation of two biological replicates northern blots. The error bar corresponds to the standard deviation of the ﬁreﬂy normalized photostimulated
luminescence signal (PSL) of the two replicates. The signal of each probe is represented in white for the normal condition (1,4), in gray for ZNF143
over-expression condition (2,5) and in black for ZNF143 knockdown conditions (3,6).
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(CCA to TTG for mut SBS/B and CCCA to AAAC for
mut SBS/C) that abolish the binding in vitro (Figures 4B
and 2E). Similar substitutions were known to be detrimen-
tal for the formation of ZNF143-DNA complex in vitro
(29). The SBS/B and C sites were also replaced by the
canonical ZNF143-binding motifs (mut SBS/B+ and mut
SBS/C+) (Figure 4B) (42). In addition to the SBS muta-
tions, we introduced individual substitution mutations
upstream of the SBS/B (Mut 1, position +55/+62 in
Figure 4B) and upstream of the SBS/C (Mut 2, position
+81/+92; mut 3, position+93/+105; mut 4, position+118/
+122; mut 5, position+126/+133; Figure 4B) in the region
conserved in vertebrate genomes (Figure 2C). No muta-
tions have been introduced in positions +106/+117 so as
not to disrupt the intron splicing mechanism. We followed
the TSS1 and TSS2 transcripts in normal and ZNF143
over-expression conditions by northern blot (Figure 4C).
We used speciﬁc probes (Figure 4A) recognizing the TSS1
transcript (probe 1) or the TSS2 transcript (probe 2). A
probe recognizing the ﬁreﬂy luciferase transcript was used
to normalize the signal and a GAPDH speciﬁc probe was
used as a loading control. The results obtained with wild-
type (WT) construct show that the over-expression of
ZNF143 causes a loss of TSS1 transcript and an increase
of the TSS2 transcript level (Figure 4C, compare lanes
1 and 2). This switch of initiation is not affected by the
ﬁve mutations (mut 1 to mut 5) performed in the conserved
blocks (Figure 4C, lanes 3–12, take into account ﬁreﬂy nor-
malization). While the SBS (SBS/C and SBS/B) mu-
tations result in no variation of the TSS1 transcript level
after induction (lanes 13 and 14), the SBS+mutation (high-
afﬁnity canonical ZNF143-binding sites: SBS/C+and SBS/
B+) completely abolish the expression of the TSS1 (lanes 15
and 16). This shows that the ZNF143 binding on low-
afﬁnity SBS/B and SBS/C sites is essential for the down-
regulation of the TSS1 after induction. The TSS2 increased
expression following induction is affected by the SBS
mutation. Indeed, the northern blot shows a TSS2 signal
decreased by 50% compared to the WT construct
(Figure 4C, lanes 13 and 14, take into account ﬁreﬂy nor-
malization). However, while the high-afﬁnity SBS sites
(mut SBS+) result in an elevated expression of TSS2, the
response to induction is abolished. In this condition, the
TSS2 transcript is constantly expressed independently
from the ZNF143 over-expression (Figure 4C, lanes 15
and 16). Taken together, the results show that the TSS
switch mechanism from TSS1 to TSS2 following the induc-
tion is dependent on ZNF143 protein levels and on the low-
afﬁnity SBS sites. This observation is conﬁrmed by the
higher in vivo occupancy observed by ChIP after ZNF143
over-expression (Figure 2G). However, in our experimental
conditions, the TSS2 transcription is not fully abolished
after induction in SBS mutant conditions and this will
be discussed later.
The auto-regulation mechanism functions both in ZNF143
over-expression and down-regulation conditions
We recapitulated the previous observations by following
the expression of the reporter luciferase (Figure 4A) gene
in induced or non-induced FLP143 cells. Individual (mut
SBS/C, mut SBS/B) or simultaneous mutations of the SBS
motifs (mut SBS) in non-induced conditions affect
slightly the luciferase activity (Figure 4D, left panel). In
cells over-expressing ZNF143, the luciferase activity of the
WT construct dropped to 20% of the level of non-induced
cells. On the other hand, it is only reduced to 40% and
33% of the non-induced signal with the individual muta-
tions in SBS/C (mut SBS/C) or SBS/B (mut SBS/B)
motifs, respectively. Remarkably, the simultaneous
mutation of both the SBS/C and SBS/B (mut SBS in
Figure 4D, left panel) sites almost completely abolish the
decrease in luciferase activity in induced conditions.
Furthermore, the luciferase activity from the SV40
promoter construct used as a control is not affected by
ZNF143 over-expression. The above results obtained
with the minimal promoter (73/+234) were fully
recapitulated with the largest promoter region (593/
+234) (data not shown).
Next, we used the SH1_7 inducible stable cell line, to
follow the luciferase activity of the same constructs in
ZNF143 knockdown conditions (Figure 4D, right
panel). After the induction with doxycycline, the SH1_7
cells produce shRNA molecules targeting the ZNF143
messenger RNA, resulting in a speciﬁc protein
knockdown (Figure 4E, left panel). Surprisingly, we
did not observe any variation in the ZNF143 mRNA
level following induction (Figure 4E, right panel).
The luciferase activity of the SV40 construct used as a
control is not affected by ZNF143 knockdown
(Figure 4D, right). With the WT construct we observed
a 50% increase of the luciferase activity reduced to only
20% with the construct containing the simultaneous SBS/
C and SBS/B mutations (mut SBS in Figure 4D).
This ZNF143-mediated down- or up-regulation of the
luciferase activity is most likely linked to a variation in the
TSS1 and TSS2 transcripts levels. We hypothesized that
the transcription of the TSS1 spliced mRNA results in
higher luciferase activity than that of the unspliced TSS2
initiated transcript. This difference could be due to their
relative abundance or could be intrinsically linked to the
mRNA sequence and affect the stability, nuclear export or
translation efﬁciency. We followed by northern blot the
two transcripts in normal, ZNF143 over-expression and
ZNF143 knockdown conditions. As previously, we used
speciﬁc probes recognizing the TSS1 transcript (probe 1),
the TSS2 transcript (probe 2) and both transcripts (probe
3) (Figure 4A). The raw northern-blot signal for the WT
ZNF143 and the SV40 promoter is shown in Figure 4F
(left panel). There is no detectable TSS1 and TSS2 signals
in the SV40 control construct (Figure 4F, lanes 4–6). To
be compared, all the speciﬁc signals were quantiﬁed and
normalized to the ﬁreﬂy and GAPDH levels (Figure 4F,
right part). As expected, after ZNF143 over-expression,
the TSS1 level drops down drastically, while the TSS2 in-
creases signiﬁcantly (lanes 1 and 2). On the other hand, in
ZNF143 knockdown conditions, we observed a decrease
in TSS2 level and an increase of TSS1 (lanes 1 and 3). The
whole Renilla transcript level stays relatively stable after
ZNF143 over-expression and increases noticeably after
ZNF143 knockdown (Figure 4F, probe 3).
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The northern-blot analysis endorsed the expected
results (Figure 4D) and validates the hypothesis for an
auto-regulatory mechanism of ZNF143 expression
mediated by a TSS switch that depends on the low or
high protein level.
ZNF143 levels ﬂuctuate during cancer, development
and differentiation
In our previous work, we showed that ZNF143 could be
important for rapid cell proliferation (22). In this regard,
we wanted to inspect ZNF143 gene expression levels in
highly proliferative cells like in tumors and developmental
tissues. We ﬁrst followed by RT-qPCR the ZNF143 tran-
script level in several mouse tissues from 13, 15 and
18 days embryos, from 7 days post-natal mice and
5 weeks adult. The over whole ZNF143 level is decreasing
progressively with the increasing developmental stage
(Figure 5A; Supplementary Figure S5A). The 5 weeks
adult mice have an over whole 80% lower ZNF143
expression level than the 13 days embryo (Figure 5A).
ZNF143 expression is also increased in certain human
tumors compared to normal tissues (Figure 5B).
ZNF143 levels are rapidly increasing with the breast
tumor developmental stage, reaching a 10 times over-
expression in cancer stage IV compared to normal
tissues. A similarly higher expression of ZNF143 was
observed in liver and lung tumors (Supplementary
Figure S5B). Instead, in kidney tumors (Figure 5B) as
well as in ovary and prostate tumors (Supplementary
Figure S5B), ZNF143 expression stays constant
compared to normal tissues.
These observations show that in some situations
ZNF143 levels ﬂuctuate within a high range without
being auto-regulated. Endogenous ZNF143 mRNA
levels can even reach a 10-fold increased expression like
in breast cancer. High ZNF143 expression seems to be
associated with fast-proliferative cells like during the em-
bryonic development or in tumors. Instead, differentiated
and normal tissues seem to require a lower ZNF143
expression.
DISCUSSION
We previously showed that the transcription factor
ZNF143 is involved in the control of genes related to
rapid cell proliferation (22). Such a factor regulating cell
growth processes must be tightly regulated to maintain the
correct function of the cells.
We observed that following ZNF143 artiﬁcial over-
expression there is a decreased expression of the endogen-
ous gene. This down-regulation is directly linked to the
DNA-binding speciﬁcity of the ectopically produced
ZNF143 protein. We showed that this speciﬁc down-
regulation is reversible and correlates with an increased
ZNF143 occupancy on its own promoter region. In
addition to the canonically initiated ZNF143 transcript
(TSS1 transcript), we identiﬁed an alternative ZNF143
transcript (TSS2 transcript) initiated downstream of the
TSS1. The balance between the canonical TSS1 and the
alternative TSS2 usage is responsible for the ZNF143
transcriptional auto-regulation mechanism. Both the
TSS1 and TSS2 initiated transcripts have the same
coding potential but differ by their 50 UTR. The most
abundant TSS1 transcript has a short 50 UTR and
permits an efﬁcient ZNF143 protein production. On the
other hand, the less abundant TSS2 transcript has a long
50 UTR originating from alternative non-coding exons
located in the canonical intronic region and is poorly
translated.
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Figure 5. ZNF143 level is up- or down-regulated during development, cancer and differentiation. (A) qPCR arrays for ZNF143 gene expression
analysis were performed on multiple tissues during mouse development. The bar chart for each developmental stage (embryo, post-natal and adult)
corresponds to the mean expression in various tissues (see Supplementary Figure S5). The error bar corresponds to the standard deviation of the
ZNF143 relative expression measured in all the tissues at the same developmental stage (Figure S5A). The ZNF143 expression in each tissue
corresponds to the mean of two replicates, normalized against GAPDH levels. (B) qPCR array for ZNF143 gene expression analysis performed
on a panel of human breast and kidney tumor at different stages versus normal tissues. Error bars are standard deviation from two replicates. The
ZNF143 expression was normalized against ß-actin levels.
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The ZNF143 transcriptional auto-regulation mechan-
ism is protein-dependent, since by treating the FLP143
cells with cycloheximide, we abolished the down-
regulation of ZNF143 (data not shown). We did not
detect any anti-sense transcript and did not observe any
effect on ZNF143 auto-regulation after knocking down
the exosome complex (data not shown). A mechanism
involving a TSS switch and that is responsive to
ZNF143 protein level was, in our opinion, the only plaus-
ible hypothesis that we conﬁrmed using an heterologous
reporter system.
The TSS switch mechanism is dependent of ZNF143
low-afﬁnity binding sites that are not required for the
activity of the ZNF143 promoter. In the human genome,
these binding sites are located downstream of the ZNF143
promoter in a highly conserved non coding region of 98 bp
exhibiting 100 and 71% identity with the orthologous
regions of the mouse and zebraﬁsh genomes respectively.
Such conservation of a genomic non-coding region is
highly indicative of an important transcriptional mechan-
ism conserved in all vertebrates (43). The non-canonical
nature of the ZNF143-binding sites is critical for the
control mechanism. Indeed, the conversion of the SBS/B
and C sites into canonical sites removes totally the regu-
lation control and the transcription is initiated on the
TSS2 independently of the ZNF143 protein level.
Following the mutation impairing the in vitro ZNF143
binding on SBS/B and C sites, the TSS1 transcription is
not anymore responsive to the ZNF143 over-expression in
contrast to the TSS2 transcription that is still slightly
efﬁcient. This could be explained by a weak ZNF143
binding on mutated SBS/C and SBS/B sites in vivo that
would affect only the TSS2 transcription. We cannot
exclude that the SBS/A site could be also bound by
ZNF143 in vivo and participate in the TSS2 transcription.
Nevertheless, the non-canonical SBS-binding sites are
per se sensors for ZNF143 protein level and constitute
an element that we deﬁne as a ‘sensor platform’. This
control region is located adjacent to the 30-part of the
promoter. Besides the sensor platform, the promoter is
recognized by other transcription factors distinct from
ZNF143. We identiﬁed binding sites validated by ChIP-
Seq for GABPA (35) and NFYA (44) transcription factors
upstream of the canonical TSS. These sites are essential
for the general promoter activity but have no impact on
ZNF143 auto-regulation (data not shown).
Our results allowed us to propose a model for a
ZNF143 auto-regulation mechanism that maintains its
adequate level in the cell (Figure 6). In ZNF143 protein
over-expression conditions, the increased occupancy of
the ‘sensor platform’ results in the production of the
TSS2 transcript. Lower ZNF143 gene expression
combined with a poor translation efﬁciency of the TSS2
transcript results in low protein production to equilibrate
the level of the factor in the cell. When the ZNF143
protein is under-expressed, the lowered occupancy on
the sensor platform results in high TSS1 transcription.
Thus, this leads to high protein production to equilibrate
the transcription factor shortage in the cell.
Interestingly, we noticed that following the induction of
our SH1_7 cell line, we could observe only a knockdown
of the protein, while the ZNF143 mRNA remained stable
(Figure 4E). This observation could be reasonably ex-
plained by the above-mentioned ZNF143 auto-regulatory
mechanism.
It is noteworthy to point out that ZNF76 over-
expression also induced ZNF143 down-regulation. This
observation was not surprising since the two proteins
have the same DBD (31) and occupies the same binding
site in vivo (22). Moreover, ZNF76 transcription is not
affected by itself neither by the ZNF143 protein. We
observed that ZNF76 protein level is very low in HeLa
and 293 T-rex cells and is detectable by western blot
only after immunoprecipitation from 108 cells (data not
shown). If both proteins have redundant functions, we
hypothesize that ZNF76 would have been maintained
during evolution as a safety measure to keep a basal
ZNF143 transcription factor level in the cell.
Despite its auto-regulatory feedback loop, we observed
that ZNF143 level is ﬂuctuating in tumors and develop-
ment. In stage IV breast cancer, for example, ZNF143 is
10 times more expressed than in normal tissue. In these
situations we could speculate that ZNF143 escapes
somehow from its auto-regulation. This evasion could be
mediated by external stimuli that have been already
reported to affect ZNF143 expression, such as lactogenic
hormones (45), insulin-like growth factor-1 (46) or the
calcium levels affect ZNF143 expression (47). In this
respect, a putative NFAT5-binding site located in the
98 bp highly conserved element covering the sensor
platform could be likely related to the ZNF143 calcium
dependent regulation. Nonetheless, how the transcrip-
tional auto-regulation is switched on or off, need to be
further investigated.
Figure 6. A model for ZNF143 auto-regulatory feedback loop. The
ZNF143 gene expression control relies on the balance between TSS1
and TSS2 transcription initiation. This balance is adjusted by a sensor
platform containing non-canonical SBS sites (represented in yellow).
The low occupation by ZNF143 of the sensor platform leads to the
stimulation of the transcription of the TSS1 transcript and a decreased
transcription of the TSS2 transcript. In ZNF143 over-expression con-
ditions, the increased occupation of the sensor platform restricts the
expression of TSS1 transcript in favor of the weakly expressed TSS2
transcript.
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Around 35% of human coding genes contain introns in
the 50 UTR, in particular genes with regulatory roles (48).
Alternative promoter usage and alternative 50 UTRs are
well known to be involved in gene expression regulation
(1). Nevertheless, as far as we know, there is no example of
transcription factor auto-regulation involving a TSS
switch mechanism relaying on a sensor platform contain-
ing non-canonical binding sites to generate transcripts
with alternative 50 UTR.
Having discovered that ZNF143 level is maintained
in the cell through an auto-regulatory feedback loop
involving a TSS switch, we scrutinized the publicly avail-
able ENCODE ChIP-seq data to reveal if this mechanism
could be also used by other transcription factors. Of the
118 ENCODE transcription factors (49) we selected only
the sequence-speciﬁc transcription factors and as for
ZNF143, we were interested in the regulatory region
located between the TSS and the CDS, including the
eventual non-coding exons and introns. Using UCSC
table browser (50) we extracted the ENCODE ChIPseq
signal track and overlapped with the transcription
factors regulatory regions. For each factor, the cluster
score represents the strength of the ChIP-seq signal that
is inﬂuenced by the afﬁnity of the factor to one or more
binding sites present in the cluster. The resulting table is
available in supplementary material (Supplementary
Table S2). Surprisingly, of the 87 sequence-speciﬁc tran-
scription factors, we found that 39 of them have at least
one binding event in their own regulatory region
(Figure 7A and B). Among these factors, 12 have no
intron in their regulatory region while 27 contain at least
an intron in their 50 UTR (Figure 7B). As for ZNF143
some of these factors, such as CTCF and NRSF, have a
non-coding ﬁrst exon and a binding site in their ﬁrst
intron. We hypothesize that these 39 transcription
factors could be subjected, like ZNF143, to an auto-
regulatory feedback loop.
To summarize, we identiﬁed in this study a novel auto-
regulatory mechanism that involves a switch of TSSs and
that relies on non-canonical binding sites usage. We un-
covered this mechanism using ZNF143 gene as a model,
but many more transcription factors could be subjected to
such a transcriptional auto-regulatory feedback loop using
alternative TSS and low-afﬁnity binding sites to maintain
their right level in the cell.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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ENCODE ChIP Transcription factors
No binding site 
Binding site 
48 39
MXI1 3 no MEF2A 1 yes
SPI1 1 no CTCF 16 yes
FOSL1 2 no STAT3 6 yes
YY1 1 no BRCA1 3 yes
SP2 1 no ZBTB7A 6 yes
JUND 1 no ZNF274 2 yes
USF2 1 no STAT1 1 yes
E2F6 1 no FOXA2 1 yes
FOSL2 1 no CTCFL 1 yes
E2F1 2 no NR2C2 1 yes
SRF 1 no REST/NRSF 2 yes
THAP1 2 no MEF2C 2 yes
RFX5 1 yes IRF1 1 yes
ATF3 3 yes BCLAF1 2 yes
ZNF143 1 yes ESR1 5 yes
SP1 1 yes MAFK 1 yes
STAT2 1 yes NRF1 1 yes
ELF1 1 yes PBX3 1 yes
MAX 1 yes GATA1 1 yes
TCF12 1 yes
Transcription 
factor
Number of 
binding events
Intron 
Region from TSS to CDS Region from TSS to CDS
Transcription 
factor
Number of 
binding events
Intron 
A B
Figure 7. Transcription factors potentially subjected to an auto-regulation. (A) Pie chart depicting the proportion of the 87 sequence-speciﬁc
transcription factors from ENCODE ChIP-seq experiments (49) having a binding event in their own 50 non-coding region (50 non-coding exon
and introns located before the CDS). (B) Table summarizing the number on binding events found in the 50 non-coding region of the 39 sequence-
speciﬁc transcription factors. For each factor the presence or absence of at least one intron in the 50 non-coding region is mentioned.
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